MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
Abstract Numerous vaccine candidates against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are under development.The majority of vaccine candidates to date are designed to induce immune responses against the viral spike (S) protein, although different forms of S antigen have been incorporated.To evaluate the yield and immunogenicity of